公开(公告)号：US20140378474A1

公开(公告)日：2014-12-25

申请号：US14371457

申请日：2013-01-25

Applicant: NOVARTIS AG

Inventor： Stefanie Flohr ,  Christian Markert ,  Kenji Namoto ,  Bernard Pirard

IPC: C07D471/04 ,  C07D401/14 ,  A61K31/4155 ,  C07D403/10 ,  C07D231/14 ,  C07D413/14 ,  A61K31/497 ,  C07D401/06 ,  A61K31/4439 ,  C07D403/14 ,  A61K31/422 ,  A61K31/4709 ,  C07D403/12

CPC classification number: C07D471/04 ,  A61K31/4155 ,  A61K31/422 ,  A61K31/4439 ,  A61K31/4709 ,  A61K31/497 ,  C07D231/14 ,  C07D401/06 ,  C07D401/14 ,  C07D403/10 ,  C07D403/12 ,  C07D403/14 ,  C07D413/14

Abstract: The invention relates to a compound of the formula (I) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

Abstract translation: 本发明涉及式（I）化合物，其中取代基如说明书中所定义; 以游离形式或盐形式; 作为其制备，用作药物和包含它的药物。